153 results for Epithelium
153 results for Epithelium
g-loxP2_C9 - Guide  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
BALB/c mouse - Model System  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
mTmG mouse - Model System  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
sgAi9R - Guide  - [In Vivo, In Vitro] [Delivery Systems Initiative] [Human, Mouse] |
SaCas9 - Genome Editor  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
scAAV5-Cre-GFP - Vector  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
- Antibody  - [In Vivo] [Delivery Systems Initiative] [Mouse]Anti-alpha Tubulin (Mouse) Monoclonal Antibody, dilution used 1:200 |
Testing AAV5 for activation of tdTomato in mouse airway club and ciliated cells - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
- Antibody  - [In Vivo] [Delivery Systems Initiative] [Mouse]Anti-CC10 (Rabbit) Polyclonal Antibody, dilution used 1:2,000 |
- Antibody  - [In Vivo] [Delivery Systems Initiative] [Mouse]Anti-RFP (Rabbit) Polyclonal Antibody |
BCM_ssAAV5-Sp_sgA - Guide  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
BCM_ssAAV5-Sp_sgB - Guide  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
SpyCas9 g-loxP2_C9 - Guide  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
[Validation] Validation for Gao Delivery Team: Testing ssAAV5 delivered intratracheally for editing activity in lung epithelia in Ai9 mice - Experiment  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Testing Shuttle Peptides ability to deliver GFP-NLS to airway epithelia. - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
SaCas9-Lagor - Genome Editor  - [In Vivo] [Delivery Systems Initiative] [Mouse]
|
AAV9-Ai9-sgRNA2-CB-SaCas9 - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAVcc47-Ai9-sgRNA1 + sgRNA2 - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
*MOCK VIRUS TROPISM STUDY* For Toolkit demonstration purposes only - Experiment  - [In Vivo] [DCC] [Mouse] |
AAV Tropism project - Experiment  - [In Vivo] [AAV tropism] [Mouse] |
AAV6-ZsGreen-Cre - Vector  - [In Vivo] [AAV tropism] [Mouse]
|
AAVrh10-ZsGreen-Cre - Vector  - [In Vivo] [AAV tropism] [Mouse]
|
AAVrh74-ZsGreen-Cre - Vector  - [In Vivo] [AAV tropism] [Mouse]
|
Testing virus region 4 (VR4) mutant cross-species compatible Adeno Associated Viruses (ccAAVs) in mice. - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
C57BL/6 mouse (Asokan study) - Model System  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAVcc84-GFP - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
- Antibody  - [In Vivo] [Delivery Systems Initiative] [Mouse]GFP (D5.1) XP Rabbit mAb antibody |
AsCas12a (IDT and Feldan Therapeutics) - Genome Editor  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
SauCas9 - Genome Editor  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Ai9 SaCas9 Guide A - Guide  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
BCM_ssAAV5-Sa_sgB - Guide  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
[Validation] Validation for McCray Delivery Team: Delivery of CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic Peptides - Experiment  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
D10 - Delivery System  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Testing new LNPs (lipid nanoparticles) for delivery of Fluc mRNA in adult mice - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Ai9-SauSpyCas9 mouse - Model System  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
AAV-Pcsk9 - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
mTmG mouse (congenic) - Model System  - [In Vivo] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse]
|
Comparing CRISPR/Cas9 gene editing efficiencies between AAV9 and AAVcc47 in Ai9 mice with a 1:3 Cas9 to sgRNA ratio (CMV promoter) - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAV9-CMV-SaCas9 - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse]
|
AAVcc47-Ai9-sgRNA1-CB-SaCas9 - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAVcc47_pTR_self comp 2xU6-Ai9 guides - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAVcc47-CMV-SaCas9 - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAVcc47-CMV-Cre - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAV4-ZsGreen-Cre - Vector  - [In Vivo] [AAV tropism] [Mouse]
|
AAV9-ZsGreen-Cre - Vector  - [In Vivo] [AAV tropism] [Mouse]
|
AAVrh8-ZsGreen-Cre - Vector  - [In Vivo] [AAV tropism] [Mouse]
|
306-O12B - Delivery System  - [In Vivo, In Vitro] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse]
|
AAV9-GFP - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAV9-mCherry - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
306-S10 - Delivery System  - [In Vivo, In Vitro] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse]
|
[Validation] Validation for Asokan Delivery Team: Evolving High Potency AAV Vectors for Neuromuscular Genome Editing. - Experiment  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
AAVcc47-SaCas9-Ai9 - Vector  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Ai9 SaCas9 Guide B - Guide  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
FSD315 - Delivery System  - [In Vitro] [Delivery Systems Initiative] [Human] |
Testing preparation for validation at The Jackson Laboratory Small Animal Testing Center - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Other Id:
A21202
Invitrogen, Donkey anti-mouse alexafluor 488 |
sg298 - Guide  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
L2-modified - Guide  - [In Vivo, In Vitro] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse] |
STS159 (mTmG; Sp_t2:Sp_c20_mTmG) - Guide  - [In Vivo, In Vitro] [Delivery Systems Initiative] [Mouse] |
STS204 (DNMT1; Sp_t2:Sp_c20_Dnmt1) - Guide  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Other Id:
AB_1196615
GFP (D5.1) XP Rabbit mAb antibody, Cell Signaling Technology
|
- Antibody  - [In Vivo] [Delivery Systems Initiative] [Mouse]Anti-RFP (RABBIT) Antibody |
Alt-R® S.p. Cas9 Nuclease V3 - Genome Editor  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
g-loxPbot_C12a - Guide  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
ssAAV5-sgB.saCas9 - Vector  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
SpCas9 - Genome Editor  - [In Vivo, In Vitro] [Delivery Systems Initiative, Biological Systems] [Human, Mouse] |
AAV.pU1a-SpCas9 - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
sgAi9L - Guide  - [In Vivo, In Vitro] [Delivery Systems Initiative] [Human, Mouse] |
- Antibody  - [In Vivo] [Delivery Systems Initiative] [Mouse]Anti-RFP (Mouse) Monoclonal Antibody, dilution used 1:300 |
S10 - Delivery System  - [In Vivo, In Vitro] [Delivery Systems Initiative] [Human, Mouse]
|
- Antibody  [Mouse]Chicken Polyclonal anti-NeuN antibody |
[Validation] Second site validation of Chen delivery platform using LNPs to deliver CRISPR/Cas9 to mouse inner ear - Experiment  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
RNP-NC-no ligand - Delivery System  - [In Vivo] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse] |
CleanCap® Cas9 mRNA (5moU) - Genome Editor  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
sNLS-SpCas9-sNLS - Genome Editor  - [In Vivo] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse] |
Ai14 gRNA - Guide  - [In Vivo] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse] |
On-target editing compared to 14 circle-seq nominated off-target sites of adenine base editor delivered by BE-eVLP vs AAV in the C57BL/6 liver - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
CleanCap® Fluc - Genome Editor  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
ssAAV5-sgA+sgB-U1A.GFP - Vector  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
ssAAV5-spCas9 - Vector  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
[Validation] Second site validation of Deverman delivery platform using engineered AAVs to deliver CRSIPR/Cas9 to mouse brain - Experiment  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Comparing CRISPR/Cas9 gene editing efficencies between AAV9 and AAVcc47 in Ai9 mice with a 1:1 Cas9 to sgRNA ratio (CB promoter) - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Comparing CRISPR/Cas9 gene editing efficencies between AAV9 and AAVcc47 in Ai9 mice with a 1:1 cas9 to sgRNA ratio (CMV promoter) - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Comparing CRISPR/Cas9 gene editing efficencies between AAV9 and AAVcc47 in Ai9 mice with a 1:1 Cas9 to sgRNA ratio (CMV promoter) and self complementary sgRNA vector. - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAV9-Ai9-sgRNA1-CB-SaCas9 - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAVcc47-Ai9-sgRNA2-CB-SaCas9 - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Pcsk9 adenine base editor efficiency in liver and nonliver tissue - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAVcc47-Cre - Vector  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Cre Recombinase dose escalation study in Ai9 mice - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAV3b-ZsGreen-Cre - Vector  - [In Vivo] [AAV tropism] [Mouse]
|
AAV5-ZsGreen-Cre - Vector  - [In Vivo] [AAV tropism] [Mouse]
|
AAV8-ZsGreen-Cre - Vector  - [In Vivo] [AAV tropism] [Mouse]
|
113-O12B - Delivery System  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Ai14 mouse (congenic) - Model System  - [In Vivo] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse]
|
Testing virus region 8 (VR8) mutant cross-species compatible Adeno Associated Viruses (ccAAVs) in mice. - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAVcc81-GFP - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
sg298 - Guide  - [In Vivo, In Vitro] [Delivery Systems Initiative] [Mouse] |
Other Id:
sc-17320
Sox-2 (Y-17) Antibody, Santa Cruz Biotechnology |
SpyCas9-3xNLS - Genome Editor  - [In Vivo, In Vitro] [Delivery Systems Initiative] [Human, Mouse]
|
Other Id:
13-0300Â
Thermo-Fisher, Rat anti-GFAP |
Other Id:
ab104224Â
Abcam, mouse anti-NeuN |
Other Id:
A21207
Invitrogen, Donkey anti-rabbit alexa fluor 594 |
Testing AAV5 for activation of tdTomato in mouse airway - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Shuttle peptides enable in vivo gene editing with Cas9 and Cas12a RNP in mouse airway epithelia - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
H509 AAVsc-u6-sgAI9L-U6-AI9R-U1A-EGFP (1) - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
306-O12B blank - Delivery System  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Cre recombinase - Genome Editor  - [In Vivo, In Vitro] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse]
|
R2-modified - Guide  - [In Vivo, In Vitro] [Delivery Systems Initiative] [Mouse] |
SpCas9 - Genome Editor  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Ai9 mouse (BCM) - Model System  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
BI28:AAV-GFAP-SaCas9-WPRE3-pA - Vector  - [In Vivo] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse] |
D237 - Delivery System  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
AAV9-Ai9-sgRNA1 + sgRNA2 - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAV9_pTR_self comp 2xU6-Ai9 guides - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Ai9 mouse - Model System  - [In Vivo] [Small Animal Testing Center (SATC), DCC, AAV tropism, Delivery Systems Initiative] [Mouse]
|
TadA-8e V106W - Genome Editor  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
eVLP - Delivery System  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
C57BL/6J mouse - Model System  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAV9-CMV-Cre - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
AAV - Delivery System  - [In Vivo] [DCC, AAV tropism, Delivery Systems Initiative] [Mouse] |
AAV7-ZsGreen-Cre - Vector  - [In Vivo] [AAV tropism] [Mouse]
|
AAVcc47-mCherry - Vector  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain. - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
Ai14 mouse - Model System  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
[Validation] Second site validation of Gong delivery platform using RNP-loaded nanocages to deliver CRISPR/Cas9 to mouse brain - Experiment  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
RNP-NC-RVG - Delivery System  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
Other Id:
Rockland Cat# 600-401-379
Anti-RFP (RABBIT) Antibody |
Other Id:
ab150155
Abcam, Donkey anti-rat alexa fluour 647 |
[Validation] Repeat experiment of second site validation of Chen delivery platform using LNPs to deliver CRISPR/Cas9 to mouse inner ear - Experiment  - [In Vivo] [Small Animal Testing Center (SATC)] [Mouse] |
RNP-NC-CPP - Delivery System  - [In Vivo] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse] |
Testing gRNA sequence and gRNA scaffold modified in Ai9 mice. - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
SaCas9 - Genome Editor  - [In Vivo, In Vitro] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse] |
BI28:AAV-GFAP-NLS-GFP-WPRE-synpA-L1-R2 - Vector  - [In Vivo] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse] |
L1-modified - Guide  - [In Vivo, In Vitro] [Small Animal Testing Center (SATC), Delivery Systems Initiative] [Mouse] |
Testing new LNPs (lipid nanoparticles) for delivery of Cas9 mRNA/sgRNA in adult mouse cochlea - Experiment  - [In Vivo] [Delivery Systems Initiative] [Mouse] |
CleanCap® Cas9 - Genome Editor  - [In Vivo, In Vitro] [Delivery Systems Initiative] [Mouse] |
Other Id:
25-6790
Anti-Myosin VIIa antibody, Proteus Biosciences |
153 results for Epithelium
Category | Type | Name | Description | Last Updated Date | View Associated.. |
---|---|---|---|---|---|
Genome Editor | Reporter | GFP-NLS | Nuclear targeted GFP | ||
Guide | g-loxP2_C9 | This sgRNA targets the Ai9 and related transgenes | |||
Model System | Animal | BALB/c mouse | BALB/cJ is a commonly used inbred. Key traits include a susceptibility to developing the demyelinating disease upon infection with Theiler's murine encephalomyelitis virus. The BALB/cJ substrain is susceptible to Listeria, all species of Leishmania, and several species of Trypanosoma, but is resistant to experimental allergic orchitis (EAO). | ||
Model System | Animal | mTmG mouse | ROSAmT/mGÂ is a cell membrane-targeted, two-color fluorescent Cre-reporter allele. Prior to Cre recombination, cell membrane-localized tdTomato (mT) fluorescence expression is widespread in cells/tissues. Cre recombinase expressing cells (and future cell lineages derived from these cells) have cell membrane-localized EGFP (mG) fluorescence expression replacing the red fluorescence | ||
Guide | sgAi9R | This sgRNA targets the Ai9 and related transgenes | |||
Genome Editor | Cas Nuclease | SaCas9 | |||
Vector | Viral Vector | scAAV5-Cre-GFP | |||
Antibody | Anti-alpha Tubulin (Mouse) Monoclonal Antibody, dilution used 1:200 | ||||
Experiment | In Vivo | Testing AAV5 for activation of tdTomato in mouse airway club and ciliated cells | AAV2/5 mediated gene editing in the mouse airway was tested by deliverying SpCas9 and guide RNAs targeting the Ai9 transgene in Ai9 transgenic mice. Gene editing quantified by tdTomato activation and cell specific markers for club and ciliated cell types. | 2021-09-21 | |
Antibody | Anti-CC10 (Rabbit) Polyclonal Antibody, dilution used 1:2,000 | ||||
Antibody | Anti-RFP (Rabbit) Polyclonal Antibody | ||||
Antibody | RRID:AB_2717534 | rabbit polyclonal antibody against the pulmonary-associated surfactant protein C (SPC), unconjugated, PA5-71680, Invitrogen | |||
Guide | BCM_ssAAV5-Sp_sgA | This sgRNA targets the Ai9 and related transgenes | |||
Guide | BCM_ssAAV5-Sp_sgB | This sgRNA targets the Ai9 and related transgenes | |||
Guide | SpyCas9 g-loxP2_C9 | This sgRNA targets the mTmG transgene | |||
Experiment | In Vivo | Validation for Gao Delivery Team: Testing ssAAV5 delivered intratracheally for editing activity in lung epithelia in Ai9 mice | AAV5 encoding CRISPR/Cas editing machinery were delivered to the lungs of reporter mice by intratracheal instillation. After 4 weeks incubation, the mice were dissected and the lungs imaged for the presence of tdTomato fluorescence, indicating successful editing. Editing calculated by dividing the number of tdTomato+ red cells by the number of nuclei in each airway | 2021-03-30 | |
Experiment | In Vivo | Testing Shuttle Peptides ability to deliver GFP-NLS to airway epithelia. | Delivery of GFP via shuttle peptides to mouse airway epithelium via nasal instilation. Delivery efficiency was quantified in large and small airways by counting the number of GFP positive cells divided by the number of DAPI cells. | 2020-11-02 | |
Genome Editor | Cas Nuclease | SaCas9-Lagor |
|
||
Vector | Viral Vector | AAV9-Ai9-sgRNA2-CB-SaCas9 | AAV serotype 9 delivering gRNA 2 + CB SaCas9 targeting the Ai9 locus | ||
Vector | Viral Vector | AAVcc47-Ai9-sgRNA1 + sgRNA2 | AAV serotype 9 delivering u6 promoter driving sgRNA 1 + sgRNA2 targeting the Ai9 locus | ||
Experiment | In Vivo | *MOCK VIRUS TROPISM STUDY* For Toolkit demonstration purposes only | *MOCK STUDY* for demonstration purpose only. Data is fake. Five viral vector serotypes delivering Cre recombinase were tested by intravenous delivery into Ai9 mice and chacterized for biodistribution across 20 tissues by quantitative PCR and imaging. Cirulating IL-6 levels as well as cellular toxicity in the kidney were assessed 1-week post inoculation. | 2023-02-21 | |
Experiment | In Vivo | AAV Tropism project | Ten AAV serotypes delivering Cre recombinase were tested by intravenous delivery into Ai9 mice and chacterized for biodistribution across 20 tissues by quantitative PCR and imaging | 2023-02-10 | |
Vector | Viral Vector | AAV6-ZsGreen-Cre | AAV backbone with a bi-directional promoter driving zsGreen and Cre |
|
|
Vector | Viral Vector | AAVrh10-ZsGreen-Cre | AAV backbone with a bi-directional promoter driving zsGreen and Cre |
|
|
Vector | Viral Vector | AAVrh74-ZsGreen-Cre | AAV backbone with a bi-directional promoter driving zsGreen and Cre |
|
|
Vector | Viral Vector | demo VV02-Cre | DEMO viral vector for demo purpose | ||
Experiment | In Vivo | Testing virus region 4 (VR4) mutant cross-species compatible Adeno Associated Viruses (ccAAVs) in mice. | C57BL/6 mice (N=3) were injected intravenously at a dose of 5e13 vg/kg per mouse with a self-complementary AAV9 or ccAAV vector encoding an mCherry reporter. The biodistribution of of virus transduction was chacterized in various tissues and cell types by fluorescence imaging quantification. | 2020-11-19 | |
Model System | Animal | C57BL/6 mouse (Asokan study) | |||
Vector | Viral Vector | AAVcc84-GFP | AAV2/9 self complementary vector with capsid variant cc84 expressing GFP driven by CBh promoter | ||
Antibody | GFP (D5.1) XP Rabbit mAb antibody | ||||
Genome Editor | Cas Nuclease | AsCas12a (IDT and Feldan Therapeutics) | |||
Genome Editor | Cas Nuclease | SauCas9 | |||
Guide | Ai9 SaCas9 Guide A | This gRNA targets the Ai9 and related transgenes | |||
Guide | BCM_ssAAV5-Sa_sgB | This gRNA targets the Ai9 and related transgenes | |||
Antibody | RRID:AB_310759 | rabbit polyclonal antibody against club cell secretory protein, unconjugated, 07-623, EMD | |||
Antibody | RRID:AB_2565050 | rabbit polyclonal antibody to detect cytokeratin5+ basal cells, uncojugated, 905501, Biolegend | |||
Experiment | In Vivo | Validation for McCray Delivery Team: Delivery of CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic Peptides | Ribonucleoproteins for CRISPR/Cas9 editing are complexed with amphiphilic peptides for delivery to lung airway epithilia via intranasal instillation into mTmG reporter mice. Editing is detected by production of GFP protein, and green fluorescence in airway linings | 2021-09-07 | |
Delivery System | Amphiphilic peptide | D10 | |||
Experiment | In Vivo | Testing new LNPs (lipid nanoparticles) for delivery of Fluc mRNA in adult mice | Delivery of firefly luciferase mRNA via new Lipid NanoParticles by tail vein injection into WT C57BL/6J mice targeting the Liver and delivery is measured by luciferase expression. | 2021-04-13 | |
Model System | Animal | Ai9-SauSpyCas9 mouse | Ai9-SauSpyCas9 is a version of Ai9 that has a single guide RNA sites on both sides of the STOP cassette. This is a Cre reporter allele that has a loxP-flanked STOP cassette preventing transcription of a CAG promoter-driven red fluorescent protein variant (tdTomato) - all inserted into the Gt(ROSA)26Sor locus. Ai9 mice express robust tdTomato fluorescence following Cre-mediated recombination. | ||
Vector | Viral Vector | AAV-Pcsk9 | |||
Model System | Animal | mTmG mouse (congenic) | mTmG is a double-fluorescent reporter transgenic mouse which expresses membrane-targeted tdTomato flanked by loxP sequences, followed by membrane-targeted GFP. After genomic cleavage by Cas9 at two sites, or Cre recombinase between loxP sites, tdTomato expression is lost and GFP is expressed. |
|
|
Experiment | In Vivo | Comparing CRISPR/Cas9 gene editing efficiencies between AAV9 and AAVcc47 in Ai9 mice with a 1:3 Cas9 to sgRNA ratio (CMV promoter) | A dual vector strategy was employed: one delivering two single guide RNAs targeting the Rosa26 locus and one delivering CMV driven SaCas9 (both single stranded AAV cassettes). This strategy was evaluted with both AAV9 (n=4) and AAVcc47 (n=5) by intravenous injection in Ai9 mice. A total dose of 4e12vg was injected into each mouse and vectors mixed in a 1:4 ratio of cas9 to guide RNA (1e12vg of CMV Sacas9 vector and 3e12vg of the sgRNA vector) and organs were harvested 4 weeks post injection. Editing efficency was determined by calculating percent TdTomato+ cells normalized to Dapi+ cells in liver and heart. | 2021-09-16 | |
Vector | Viral Vector | AAV9-CMV-SaCas9 | AAV serotype 9 delivering CMV driven SaCas9 |
|
|
Vector | Viral Vector | AAVcc47-Ai9-sgRNA1-CB-SaCas9 | AAVcc47 delivering sgRNA 1 + CB SaCas9 targeting the Ai9 locus | ||
Vector | Viral Vector | AAVcc47_pTR_self comp 2xU6-Ai9 guides | AAVcc47 delivering u6 promoter driving sgRNA 1 + sgRNA2 (self complementray vector) targeting Ai9 transgene | ||
Vector | Viral Vector | AAVcc47-CMV-SaCas9 | AAVcc47 delivering CMV driven SaCas9 | ||
Vector | Viral Vector | AAVcc47-CMV-Cre | AAVcc47 delivering CMV Cre Recombinase | ||
Vector | Viral Vector | AAV4-ZsGreen-Cre | AAV backbone with a bi-directional promoter driving zsGreen and Cre |
|
|
Vector | Viral Vector | AAV9-ZsGreen-Cre | AAV backbone with a bi-directional promoter driving zsGreen and Cre |
|
|
Vector | Viral Vector | AAVrh8-ZsGreen-Cre | AAV backbone with a bi-directional promoter driving zsGreen and Cre |
|
|
Vector | Viral Vector | demo VV03-Cre | DEMO viral vector for demo purpose | ||
Vector | Viral Vector | demo VV04-Cre | DEMO viral vector for demo purpose | ||
Delivery System | Nanoparticle | 306-O12B | Combinatorial library cationic lipid nanoparticles |
|
|
Vector | Viral Vector | AAV9-GFP | AAV2/9 self complementary vector expressing GFP driven by CBh promoter | ||
Vector | Viral Vector | AAV9-mCherry | AAV2/9 self complementary vector expressing Mcherry driven by CBh promoter | ||
Delivery System | Nanoparticle | 306-S10 | combinatorial library cationic lipid nanoparticles |
|
|
Experiment | In Vivo | Validation for Asokan Delivery Team: Evolving High Potency AAV Vectors for Neuromuscular Genome Editing. | Quantification of CRISPR/Cas editing in liver and heart following custom AAV-mediated delivery. Detection of editing in non-target tissues. | 2021-03-30 | |
Vector | Viral Vector | AAVcc47-SaCas9-Ai9 | AAV2/9 expressing SaCas9 and single sgRNA under U6 promoter | ||
Guide | Ai9 SaCas9 Guide B | This gRNA targets the Ai9 and related transgenes | |||
Delivery System | Amphiphilic peptide | FSD315 | Shuttle peptide used to deliver reagents to airway epithelia | ||
Experiment | In Vivo | Testing preparation for validation at The Jackson Laboratory Small Animal Testing Center | Delivery of chemically modified, phosphorothioate (PS)-stabilized crRNA with chemically modified, PS-stabilized tracrRNA to activate the mTmG reporter in mouse brain | 2021-10-01 | |
Antibody | AB_141607 | Invitrogen, Donkey anti-mouse alexafluor 488 | |||
Antibody | RRID:AB_10711040 | Mouse monoclonal [1B7] to NeuN - Neuronal Marker | |||
Antibody | RRID:AB_2762834 | Alexa fluor 555, Donkey anti-rabbit | |||
Guide | sg298 | This sgRNA targets the Ai9 and related transgenes at multiple sites. 2'-O-Methyl at 3 first and last bases, 3' phosphorothioate bonds between first 3 and last 2 bases | |||
Guide | L2-modified | This gRNA targets the Ai9 and related transgenes | |||
Guide | STS159 (mTmG; Sp_t2:Sp_c20_mTmG) | Targets mTmG and related reporter transgenes | |||
Guide | STS204 (DNMT1; Sp_t2:Sp_c20_Dnmt1) | For endogenous locus | |||
Antibody | RRID:AB_1196615 | GFP (D5.1) XP Rabbit mAb antibody, Cell Signaling Technology |
|
||
Antibody | Anti-RFP (RABBIT) Antibody | ||||
Genome Editor | Cas Nuclease | Alt-R® S.p. Cas9 Nuclease V3 | |||
Guide | g-loxPbot_C12a | This sgRNA targets the Ai9 and related transgenes at two sites | |||
Vector | Viral Vector | ssAAV5-sgB.saCas9 | |||
Genome Editor | Cas Nuclease | SpCas9 | HA-SV40NLS-SpCas9-SV40NLS | ||
Vector | Viral Vector | AAV.pU1a-SpCas9 | Expresses codon-optimized SpCas9 in mammalian cells. HA-SV40NLS-SpCas9-SV40NLS | ||
Guide | sgAi9L | This sgRNA targets the Ai9 and related transgenes | |||
Antibody | Anti-RFP (Mouse) Monoclonal Antibody, dilution used 1:300 | ||||
Delivery System | Amphiphilic peptide | S10 | Shuttle peptide used to deliver reagents to airway epithelia |
|
|
Antibody | Chicken Polyclonal anti-NeuN antibody | ||||
Antibody | RRID:AB_141607 | Alexa fluor 488, Donkey anti-mouse | |||
Antibody | RRID:AB_2762843 | Goat anti-chicken IgG-Alexa Fluor 488 | |||
Experiment | In Vivo | Second site validation of Chen delivery platform using LNPs to deliver CRISPR/Cas9 to mouse inner ear | Delivery of CRISPR/Cas9 via bioreducible lipid nanoparticles (LNPs) to the inner ear in Ai14 mice | 2021-04-01 | |
Delivery System | Nanoparticle | RNP-NC-no ligand | The nanocapsule is a thin glutathione (GSH)-cleavable covalently crosslinked polymer coating around a preassembled ribonucleoprotein (RNP) complex between a Cas9 nuclease and an sgRNA. | ||
Genome Editor | Cas Nuclease | CleanCap® Cas9 mRNA (5moU) | SpCas9 mRNA with 2 NLS signals, HA tag and capped using CleanCap. It is polyadenylated, substituted with a modified uridine and optimized for mammalian systems. It mimics a fully processed mature mRNA. | ||
Genome Editor | Cas Nuclease | sNLS-SpCas9-sNLS | SpCas9 with N- and C-terminal SV40 NLS | ||
Guide | Ai14 gRNA | This sgRNA targets the Ai9 and related transgenes at multiple sites | |||
Antibody | RRID:AB_10563941 | Polyclonal rabbit anti-RFP antibody | |||
Experiment | In Vivo | On-target editing compared to 14 circle-seq nominated off-target sites of adenine base editor delivered by BE-eVLP vs AAV in the C57BL/6 liver | On-target editing compared to off-target editing at 14 CIRCLE seq nominated sites in livers of an adenine base editor delivered by engineered virus-like particles (BE-eVLPs). Treated mice vs. untreated vs. AAV was assessed one week after systemic administration of BE-eVLPs or AAV-Pcsk9 to C57BL/6 mice. DNA sequencing reads containing A-T to G-C mutations within protospacer positions 4-10. | 2022-04-15 | |
Genome Editor | Reporter | CleanCap® Fluc | Firefly luciferase mRNA capped using CleanCap. It is polyadenylated, modified with 5-methoxyuridine and optimized for mammalian systems. It mimics a fully processed mature mRNA. | ||
Vector | Viral Vector | ssAAV5-sgA+sgB-U1A.GFP | |||
Vector | Viral Vector | ssAAV5-spCas9 | |||
Experiment | In Vivo | Second site validation of Deverman delivery platform using engineered AAVs to deliver CRSIPR/Cas9 to mouse brain | Validation of delivery of AAV custom designed to cross the blood-brain barrier for CRISPR/Cas9 editing. Editing detected and quantified in brain by generation of tdTomato fluorescent protein signal from Ai9 reporter mice | 2021-08-08 | |
Experiment | In Vivo | Comparing CRISPR/Cas9 gene editing efficencies between AAV9 and AAVcc47 in Ai9 mice with a 1:1 Cas9 to sgRNA ratio (CB promoter) | A dual vector strategy was employed: one delivering a single guide RNA and CB driven SaCas9, and another delivering the second guide RNA and CB driven SaCas9. This strategy was evaluted with both AAV9 (n=4) and AAVcc47 (n=5) by intravenous injection in Ai9 mice. A total dose of 2e12vg was injected into each mouse (1e12vg each vector mixed 1:1) and organs were harvested 4 weeks post injection. Editing efficency was determined by calculating percent TdTomato+ cells normalized to Dapi+ cells in liver and heart. | 2021-09-16 | |
Experiment | In Vivo | Comparing CRISPR/Cas9 gene editing efficencies between AAV9 and AAVcc47 in Ai9 mice with a 1:1 cas9 to sgRNA ratio (CMV promoter) | A dual vector strategy was employed: one delivering two single guide RNAs targeting the Rosa26 locus and one delivering CMV driven SaCas9 (both single stranded AAV cassettes). This strategy was evaluted with both AAV9 (n=3) and AAVcc47 (n=3) by intravenous injection in Ai9 mice. A total dose of 3e12vg was injected into each mouse (1.5e12vg each vector mixed 1:1) and organs were harvested 4 weeks post injection. Editing efficency was determined by calculating percent TdTomato+ cells normalized to Dapi+ cells in liver and heart. | 2021-09-16 | |
Experiment | In Vivo | Comparing CRISPR/Cas9 gene editing efficencies between AAV9 and AAVcc47 in Ai9 mice with a 1:1 Cas9 to sgRNA ratio (CMV promoter) and self complementary sgRNA vector. | A dual vector strategy was employed: one self complementary vector delivering two single guide RNAs targeting the Rosa26 locus and one delivering CMV driven SaCas9 (single stranded vector). This strategy was evaluted with both AAV9 (n=4) and AAVcc47 (n=4) by intravenous injection in Ai9 mice. A total dose of 4e12vg was injected into each mouse and vectors mixed in a 1:1 ratio of cas9 to guide RNA (2e12vg of CMV Sacas9 vector and 2e12vg of the self complementary sgRNA vector) and organs were harvested 4 weeks post injection. Editing efficency was determined by calculating percent TdTomato+ cells normalized to Dapi+ cells in liver and heart. | 2021-09-16 |